ADAPTIMMUNE THERAPEUTICS ($ADAP) is expected to release its quarterly earnings data on Monday, December 8th before market open, per Finnhub. Analysts are expecting revenue of $3,060,000 and earnings of -$0.12 per share.
You can see Quiver Quantitative's $ADAP stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ADAPTIMMUNE THERAPEUTICS Insider Trading Activity
ADAPTIMMUNE THERAPEUTICS insiders have traded $ADAP stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $ADAP stock by insiders over the last 6 months:
- CAPITAL, LLC ECOR1 has made 0 purchases and 3 sales selling 64,052,538 shares for an estimated $6,890,235.
- ALI BEHBAHANI has made 0 purchases and 2 sales selling 19,500,000 shares for an estimated $229,171.
- WILLIAM C JR BERTRAND (Chief Operating Officer) sold 207,000 shares for an estimated $2,090
- GAVIN WOOD (Chief Financial Officer) sold 96,000 shares for an estimated $950
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ADAPTIMMUNE THERAPEUTICS Hedge Fund Activity
We have seen 22 institutional investors add shares of ADAPTIMMUNE THERAPEUTICS stock to their portfolio, and 46 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ECOR1 CAPITAL, LLC removed 27,404,070 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $3,562,529
- TWO SEAS CAPITAL LP removed 22,580,701 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,935,491
- NEA MANAGEMENT COMPANY, LLC removed 17,079,778 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,220,371
- UBS GROUP AG added 6,604,400 shares (+10490.2%) to their portfolio in Q3 2025, for an estimated $858,572
- LONG FOCUS CAPITAL MANAGEMENT, LLC removed 5,178,866 shares (-21.8%) from their portfolio in Q3 2025, for an estimated $673,252
- MPM ASSET MANAGEMENT LLC removed 4,809,677 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $625,258
- MPM BIOIMPACT LLC removed 4,411,821 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $573,536
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
